Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the two pivotal Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib ...

Pfizer is pursuing pipeline expansions through the Metsera acquisition and a major licensing deal with 3SBio. Find out why ...

Guides engineers through the hardware and firmware architecture of an induction cooker, addressing power electronics, control ...

Today, Takeda announced positive topline results from 2 pivotal phase 3 trials of zasocitinib (TAK-279; Takeda), demonstrating superiority over placebo across key efficacy end points in adults with ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved WYNZORA® , a white uniform cream containing 0.

Takeda (TAK) announced topline results for the two pivotal Phase 3 randomized, multicenter, double-blind, placebo- and active ...

Clarivate Plc , a leading global provider of transformative intelligence, announced today that Nissan Motor Co., Ltd (Nissan: 7201.T) has selected IPfolio. This intellectual property management ...

This week, the Australian Treasurer enacted new regulations to outlaw excessive pricing by Australian supermarkets. These regulations will come into force on 1 July 2026. The Treasurer announced the ...

Standing on the hills of Sixian town in Fuxian county on the Loess Plateau in Shaanxi province, one can see the Baota Mountain Converter Station ? the starting point of the State Grid's Shaanbei-Anhui ...

"Takeda to seek approval of plaque psoriasis pill on Phase III trial data" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

In a significant stride towards advancing treatment options for complicated urinary tract infections (cUTIs), GSK has resubmitted a New Drug Application (NDA) to the FDA for tebipenem pivoxil ...